CoJourney
Hangzhou
About CoJourney
CoJourney is a CDMO platform for gene therapy that combines plasmid, viral vector, and mRNA generation, analysis, and detection.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Total funding: $30.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Jun 2023)
- Website: cojourney.com
- Phone: 0571-81968259
Industries & Categories
Biopharma, Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/cojourney-45901 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.